- CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapyJ Dawn Waters
Division of Neurosurgery, University of California San Diego, La Jolla, CA 92093, USA
J Neurooncol 110:37-48. 2012..These pre-clinical results provide the foundation to further understand long term response and tumor escape mechanisms to anti-angiogenic treatments on EGFR over-expressing glioblastomas...
- Malignancies of the spinal cordJ Dawn Waters
Division of Neurosurgery, University of California San Diego Medical Center San Diego, California, USA
Adv Exp Med Biol 760:101-13. 2012..This section will review the pathophysiology and epidemiology of IMSCT and the state-of-the-art management before delving into the promising new tools and techniques for each phase of management...